Agenus
AGEN
$1.06
Share price
0.95%
Change (1 day)
-58.59%
Change (1 year)
Categories
Operating Margin for Agenus (AGEN)
Operating Margin as of October 2023 (TTM): -9.71%
According to Agenus 's latest financial reports and stock price the company's current Operating Margin is -9.71%. At the end of 2021 the company had an Operating Margin of -9.72%.
Operating Margin history for Agenus from 2013 to 2012
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -9.72% | -95.32% |
| 2020 | -207.43% | 178.99% |
| 2019 | -74.35% | -83.12% |
| 2018 | -440.53% | 56.5% |
| 2017 | -281.48% | -49.97% |
| 2016 | -562.59% | 49.7% |
| 2015 | -375.82% | -38.28% |
| 2014 | -608.91% | -38.34% |
| 2013 | -987.54% | 1291.8% |
| 2012 | -70.95% | -89.76% |
| 2011 | -692.61% | 6.97% |
| 2010 | -647.47% | -22% |
| 2009 | -830.08% | -41.85% |
| 2008 | -1,427.48% | 138.17% |
| 2007 | -599.35% | -91.58% |
| 2006 | -7,114.07% | -39.37% |
| 2005 | -11,732.77% | 24.19% |
| 2004 | -9,447.36% | 520.62% |
| 2003 | -1,522.25% | -9.49% |
| 2002 | -1,681.80% | 84.03% |
| 2001 | -913.87% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -335.63% | 🇺🇸 USA |
 Merck MRK | 27.73% | -385.58% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | -298.15% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | -332.13% | 🇬🇧 UK |
 Celldex Therapeutics CLDX | -1,520.92% | 15,563.44% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.